Cited by 61Metabolism, Diabetes, and CancerNF-κB Signaling PathwaysPeroxisome Proliferator-Activated Receptors

AMPKα2 exerts its anti-inflammatory effects through PARP-1 and Bcl-6

Open access
Gongol, Brendan, Marin, Traci, Peng, I-Chen, Woo, Brian, Martin, Marcy, King, Stephanie, Sun, Wei, Johnson, David A. +2 more·2013·Proceedings of the National Academy of Sciences

Abstract

B-cell lymphoma-6 protein (Bcl-6) is a corepressor for inflammatory mediators such as vascular cell adhesion molecule-1 and monocyte chemotactic protein-1 and -3, which function to recruit monocytes to vascular endothelial cells upon inflammation. Poly [ADP ribose] polymerase 1 (PARP-1) is proinflammatory, in part through its binding at the Bcl-6 intron 1 to suppress Bcl-6 expression. We investigated the mechanisms by which PARP-1 dissociates from the Bcl-6 intron 1, ultimately leading to attenuation of endothelial inflammation. Analysis of the PARP-1 primary sequence suggested that phosphorylation of PARP-1 Serine 177 (Ser-177) by AMP-activated protein kinase (AMPK) is responsible for the induction of Bcl-6. Our results show that AMPK activation with treatment of 5-aminoimidazole-4-carboxamide ribonucleotide, metformin, or pulsatile shear stress induces PARP-1 dissociation from the Bcl-6 intron 1, increases Bcl-6 expression, and inhibits expression of inflammatory mediators. Conversely, AMPKα suppression or knockdown produces the opposite effects. The results demonstrate an anti-infamatory pathway linking AMPK, PARP-1, and Bcl-6 in endothelial cells.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.1222051110

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • AMPK exerted its anti-inflammatory roles on the vasculature partially via the inhibition of adhesion molecules and chemoattractants by regulating signal transducer and activator of transcription 3, of nuclear factor kappa B, and p300 pathways.

    “Indeed, studies have uncovered that AMPK exerted its anti-inflammatory roles on the vasculature partially via the inhibition of adhesion molecules and chemoattractants [248,249,252,253] by regulating signal transducer and activator of transcription 3, of nuclear factor kappa B, and p300 pathways [254,255,256].”

    From AMPK, Mitochondrial Function, and Cardiovascular Disease (2020) · cites this paper as [254]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

1 retracted

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Gongol, B., Marin, T., Peng, I.-C., Woo, B., Martin, M., King, S., Sun, W., Johnson, D. A., Chien, S., & Shyy, J. Y.-J.
Affiliations
  • University of California, Riverside (US)
  • Biochemistry and Molecular Biology Graduate Program, and
  • University of California San Diego (US)
Venue
Proceedings of the National Academy of Sciences
Published
2013-02-04
Volume
110
Issue
8
Pages
3161-3166
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W1986810494
Cited by
61
References
46
Citations by year
2026: 2 · 2025: 1 · 2024: 4 · 2023: 7 · 2022: 3 · 2021: 4 · 2020: 4 · 2019: 7 · 2018: 6 · 2017: 4 · 2016: 9 · 2015: 3 · 2014: 6 · 2013: 1
FWCI
2.83
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Heart, Lung, and Blood Institute (R01HL106579, HL‐080518, R01HL089940, R01HL080518, HL93731, R01HL108735, HL108735, R21HL093731, HL89940)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
Keywords
AMPKα2, PARP1, BCL6, anti-inflammatory signaling, endothelial inflammation, vascular endothelial growth factor, VCAM-1, MCP-1, MCP-3, monocyte recruitment, metformin, pulsatile shear stress, vascular inflammation
MeSH terms
Poly (ADP-Ribose) Polymerase-1, Animals, Cells, Cultured, Introns, Phosphorylation, Poly(ADP-ribose) Polymerases, Transcription, Genetic, Transcriptional Activation, Mice, Proto-Oncogene Proteins c-bcl-6, AMP-Activated Protein Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review